MPA
BIIB icon

Marvin & Palmer Associates’s Biogen BIIB Stock Holding History

Marvin & Palmer Associates’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,500
Closed -$766K – 50
2015
Q4 		$766K Hold
2,500
– – 0.78% 41
2015
Q3 		$730K Sell
2,500
-3,850
-61% -$1.27M 0.87% 39
2015
Q2 		$2.56M Sell
6,350
-50
-0.8% -$20.1K 2.43% 19
2015
Q1 		$2.7M Buy
6,400
+316
+5% +$125K 2.34% 16
2014
Q4 		$2.06M Sell
6,084
-3,121
-34% -$1.01M 2.1% 21
2014
Q3 		$3.04M Buy
9,205
+2,995
+48% +$988K 3.1% 5
2014
Q2 		$1.96M Sell
6,210
-6,490
-51% -$1.95M 1.7% 18
2014
Q1 		$3.88M Sell
12,700
-10,100
-44% -$3.21M 3.41% 6
2013
Q4 		$6.38M Sell
22,800
-275
-1% -$71.1K 3.83% 4
2013
Q3 		$5.56M Sell
23,075
-9,200
-29% -$2.06M 3.64% 3
2013
Q2 		$6.95M Buy
+32,275
New +$6.9M 3.77% 4

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Marvin & Palmer Associates's BIIB Position: Q1 2016 in Review

Marvin & Palmer Associates sold out of Biogen (BIIB) in Q1 2016, closing a stake of 2,500 shares — an estimated $766K sold.

Marvin & Palmer Associates first reported a position in BIIB in Q2 2013 and held it in 11 quarters. The position peaked at $6.95M in Q2 2013. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • Marvin & Palmer Associates reported no remaining Biogen position as of Q1 2016 after selling out during the quarter.
  • Marvin & Palmer Associates sold 2,500 Biogen shares in Q1 2016, an estimated $766K.
  • Marvin & Palmer Associates first reported a position in Biogen in Q2 2013 and held it in 11 quarters.
  • Marvin & Palmer Associates's Biogen position peaked at $6.95M in Q2 2013.
  • 948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Marvin & Palmer Associates's 13F filing for Q1 2016, filed 11 May 2016.